Literature DB >> 2093380

Imaging of myocardial metabolism by positron emission tomography.

P Rigo1, C de Landsheere, P Melon, H Kulbertus.   

Abstract

Tracer techniques have provided new insight in cardiology by allowing noninvasive studies of myocardial perfusion, function, metabolism, and, more recently, ligand-receptor interaction. Positron emission tomography allows accurate quantification and the use of natural substrates labelled with 11C, 13N, or 15O. Myocardial metabolism is complex and utilizes a number of substrates, primarily fatty acids. Fatty acids utilization can be studied with 11C palmitate, while 11C acetate more selectively traces TCA cycle activity and reflects myocardial oxygen utilization. Glucose uptake can be traced using 18F deoxyglucose, a glucose analog that is a substrate for hexokinase but is not further metabolized. Flow and oxidative glucose metabolism are usually coupled, and thereby the uptake of FDG and perfusion tracers are usually similar. In myocardial ischemia, however, glucose utilization can persist due to anaerobic glycolysis, and its uptake is frequently enhanced. Clinical applications of the use of metabolic studies in patients with ischemic heart disease are presented.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2093380     DOI: 10.1007/BF00051291

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  21 in total

1.  MYOCARDIAL UTILIZATION OF ACETATE, LACTATE AND FREE FATTY ACIDS AFTER INGESTION OF ETHANOL.

Authors:  O LINDENEG; K MELLEMGAARD; J FABRICIUS; F LUNDQUIST
Journal:  Clin Sci       Date:  1964-12       Impact factor: 6.124

2.  Extraction and release of individual free fatty acids by the heart and fat depots.

Authors:  M E ROTHLIN; R J BING
Journal:  J Clin Invest       Date:  1961-08       Impact factor: 14.808

3.  Localization of viable, ischemic myocardium by positron-emission tomography with 11C-palmitate.

Authors:  R A Lerch; H D Ambos; S R Bergmann; M J Welch; M M Ter-Pogossian; B E Sobel
Journal:  Circulation       Date:  1981-10       Impact factor: 29.690

4.  C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C- 11 palmitic acid in normal myocardium.

Authors:  H R Schön; H R Schelbert; G Robinson; A Najafi; S C Huang; H Hansen; J Barrio; D E Kuhl; M E Phelps
Journal:  Am Heart J       Date:  1982-04       Impact factor: 4.749

5.  Myocardial kinetics of fluorine-18 misonidazole: a marker of hypoxic myocardium.

Authors:  M E Shelton; C S Dence; D R Hwang; M J Welch; S R Bergmann
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057

6.  External detection and visualization of myocardial ischemia with 11C-substrates in vitro and in vivo.

Authors:  E S Weiss; E J Hoffman; M E Phelps; M J Welch; P D Henry; M M Ter-Pogossian; B E Sobel
Journal:  Circ Res       Date:  1976-07       Impact factor: 17.367

7.  Myocardial blood flow and glucose uptake after myocardial infarction.

Authors:  P Rigo; C de Landsheere; D Raets; G Delfiore; L Quaglia; C Lemaire; J M Peters; M Guillaume; D Lamotte; H Kulbertus
Journal:  Eur J Nucl Med       Date:  1986

8.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography.

Authors:  J Tillisch; R Brunken; R Marshall; M Schwaiger; M Mandelkern; M Phelps; H Schelbert
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

9.  [Atraumatic approach in myocardial perfusion, metabolism and receptors by positron emission tomography].

Authors:  A Syrota
Journal:  Arch Mal Coeur Vaiss       Date:  1988-10

Review 10.  Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography.

Authors:  P Camici; E Ferrannini; L H Opie
Journal:  Prog Cardiovasc Dis       Date:  1989 Nov-Dec       Impact factor: 8.194

View more
  3 in total

1.  [(18)F]Fluoroacetate is not a functional analogue of [(11)C]acetate in normal physiology.

Authors:  Orjan Lindhe; Aijun Sun; Johan Ulin; Obaidur Rahman; Bengt Långström; Jens Sörensen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-22       Impact factor: 9.236

2.  Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer.

Authors:  K J Mather; G D Hutchins; K Perry; W Territo; R Chisholm; A Acton; B Glick-Wilson; R V Considine; S Moberly; T R DeGrado
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-01-05       Impact factor: 4.310

3.  Imaging with non-FDG PET tracers: outlook for current clinical applications.

Authors:  Egesta Lopci; Cristina Nanni; Paolo Castellucci; Gian Carlo Montini; Vincenzo Allegri; Domenico Rubello; Franca Chierichetti; Valentina Ambrosini; Stefano Fanti
Journal:  Insights Imaging       Date:  2010-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.